Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)‘s stock had its “buy” rating reiterated by Cantor Fitzgerald in a research note issued to investors on Friday. They currently have a $30.00 price objective on the real estate investment trust’s stock. Cantor Fitzgerald’s target price suggests a potential upside of 34.29% from the company’s previous close. Cantor Fitzgerald also issued estimates for Sabra Healthcare REIT’s FY2017 earnings at $2.27 EPS and FY2018 earnings at $2.31 EPS.

The analysts wrote, “We expect investors to be pleased that SBRA’s restructuring of selected underperforming leases acquired in last months combination with CCP appears to eliminate the poor coverage issues at Signature and other operators, and demonstrate substantially more accretion from CCP than we had assumed.””

Several other research analysts have also weighed in on SBRA. Jefferies Group LLC reissued a “hold” rating and issued a $28.00 price objective on shares of Sabra Healthcare REIT in a research report on Friday, May 12th. Zacks Investment Research lowered Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Thursday, June 8th. BidaskClub raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Tuesday, June 20th. Mizuho reissued a “neutral” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, June 28th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $26.00 price objective on shares of Sabra Healthcare REIT in a research report on Friday, July 28th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company. Sabra Healthcare REIT has a consensus rating of “Hold” and an average price target of $25.29.

Sabra Healthcare REIT (SBRA) opened at 22.34 on Friday. Sabra Healthcare REIT has a 1-year low of $19.30 and a 1-year high of $29.10. The firm has a 50-day moving average price of $22.40 and a 200-day moving average price of $24.79. The firm has a market capitalization of $1.46 billion, a PE ratio of 18.80 and a beta of 0.89.

ILLEGAL ACTIVITY WARNING: “Sabra Healthcare REIT’s (SBRA) “Buy” Rating Reaffirmed at Cantor Fitzgerald” was published by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/09/08/sabra-healthcare-reits-sbra-buy-rating-reaffirmed-at-cantor-fitzgerald.html.

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Sabra Healthcare REIT by 6.4% during the 2nd quarter. Vanguard Group Inc. now owns 13,229,559 shares of the real estate investment trust’s stock valued at $318,832,000 after purchasing an additional 797,491 shares during the last quarter. BlackRock Inc. boosted its stake in Sabra Healthcare REIT by 3.0% during the 2nd quarter. BlackRock Inc. now owns 9,570,432 shares of the real estate investment trust’s stock valued at $230,649,000 after purchasing an additional 277,421 shares during the last quarter. BlackRock Fund Advisors boosted its stake in Sabra Healthcare REIT by 9.1% during the 3rd quarter. BlackRock Fund Advisors now owns 4,771,441 shares of the real estate investment trust’s stock valued at $120,145,000 after purchasing an additional 397,912 shares during the last quarter. LSV Asset Management boosted its stake in Sabra Healthcare REIT by 8.7% during the 2nd quarter. LSV Asset Management now owns 3,019,936 shares of the real estate investment trust’s stock valued at $72,780,000 after purchasing an additional 241,022 shares during the last quarter. Finally, Forward Management LLC boosted its stake in Sabra Healthcare REIT by 0.4% during the 2nd quarter. Forward Management LLC now owns 2,383,000 shares of the real estate investment trust’s stock valued at $49,173,000 after purchasing an additional 10,024 shares during the last quarter. Institutional investors and hedge funds own 99.26% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.